Indication

Complex-partial epilepsy

Complex-partial epilepsy is a neurological disorder characterized by recurrent unprovoked seizures originating within a discrete cerebral region—predominantly the temporal or frontal lobes—accompanied by an impairment of awareness or responsiveness. Read more about Complex-partial epilepsy

484 drugs 160 manufacturers

Advertisement

Drugs that treat it

Common Complex-partial epilepsy therapies.

Showing 181–189 of 484 drugs

LAMOTRIGINE

ANTICONVULSANTS·LENNOX-GASTAUT EPILEPSY·+4
ALEMBIC PHARMAC

OXCARBAZEPINE

ANTICONVULSANTS·SIMPLE-PARTIAL EPILEPSY·+3
ROXANE/WEST-WAR

OXCARBAZEPINE

ANTICONVULSANTS·SIMPLE-PARTIAL EPILEPSY·+3
ROXANE/WEST-WAR
Filter & compare in the drug finder →Opens the drug finder with Complex-partial epilepsy preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Complex-partial epilepsy.

Complex-partial epilepsy is a neurological disorder characterized by recurrent unprovoked seizures originating within a discrete cerebral region—predominantly the temporal or frontal lobes—accompanied by an impairment of awareness or responsiveness.

Affecting pediatric and adult patient populations, the condition involves localized, paroxysmal neuronal hyperexcitability and hypersynchrony that disrupts networks governing consciousness and higher cognitive functions.

Clinically, these episodes are defined by altered awareness, behavioral arrest or blank staring, semi-purposeful repetitive automatisms such as lip-smacking or manual fumbling, and frequent progression to postictal amnesia or confusion.

Under modern International League Against Epilepsy classifications, this presentation corresponds to focal impaired awareness seizures within focal epilepsy.

Personalize your experience

Follow Complex-partial epilepsy and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it